Horizon Discovery enters into agreement with Roche Diagnostics to support the development of immunohistochemistry assays for oncology
Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announces that it has entered into an agreement with Roche Diagn...
Continue Reading →
